# PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy

> **NCT04837547** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Florida** · enrollment: 24 (estimated)

## Conditions studied

- Neuroblastoma
- Diffuse Intrinsic Pontine Glioma

## Interventions

- **BIOLOGICAL:** Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT)

## Key facts

- **NCT ID:** NCT04837547
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-09-20
- **Primary completion:** 2027-09
- **Final completion:** 2032-09
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04837547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04837547, "PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04837547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*